A 2020 FDA-funded report on compounded hormones from the National Academies of Science, Engineering and Medicine recommends across-the-board restrictions on compounded hormones – restrictions that would undermine physicians and interfere with the practice of medicine. These restrictions could also prove catastrophic for millions of patients who benefit from those therapies. Unfortunately, the NASEM report is compromised by potential bias, conflicts of interest, and bad science.
APC advocates for compounding pharmacies and their patients on a range of state and federal issues affecting patient access to compounded medications.
To learn more about those issues, visit a4pc.org
Compounding exists for patients and animals who are not served by traditional pharmaceutical manufacturers. Every day, APC members play a critical, often life-or-death role in patients’ lives, creating essential medications unavailable elsewhere for a range of health conditions, including autism, oncology, dermatology, ophthalmology, pediatrics, women’s health, animal health, and others.
We routinely host live CE webinars as well as on-demand CE programs on a range of scientific and regulatory compliance issues. In collaboration with Virginia Commonwealth University and the Pharmacy Compounding Foundation, APC offers a 15-hour foundational curriculum, The Ethical, Legal and Regulatory Foundations of Pharmacy Compounding. We designed this course to help compounding professionals understand not only how to compound but also the legal and compliance framework that protects patient safety.
Explore our interactive map that demonstrates the importance of compounded medicines to patients all across the country. Filter these first-hand accounts by state to see just how vital compounded medicines are.
Our campaign to protect access to compounded hormones needs your support. We need your involvement. We need your voice. And, yes, we need your financial support as well.